RK-33 - DDX3 inhibitor. CAS# 1070773-09-9 Catalog No.:M6511-2 3-dimethyl-5-((1-(4-nitrophenyl)ethyl)carbamoyl)-1H-indol-1-yl)methyl)-[1

3-dimethyl-5-((1-(4-nitrophenyl)ethyl)carbamoyl)-1H-indol-1-yl)methyl)-[1

Muñoz-Fontela C

23)24/h5-10

Fragment-based Discovery of a Small-Molecule Protein Kinase C-iota Inhibitor Binding Post-kinase Domain Residues

MDL-29951 inhibits the human liver (IC50=2

RK-33 - DDX3 inhibitor. CAS# 1070773-09-9 Catalog No.:M6511-2 3-dimethyl-5-((1-(4-nitrophenyl)ethyl)carbamoyl)-1H-indol-1-yl)methyl)-[1DDX3 inhibitor, CAS No. 1070773 09 9, RK 33 binds to DDX3 and abrogates its activity. Inhibition of DDX3 by RK 33 caused G1 cell cycle arrest, induced apoptosis, and promoted radiation sensitization in DDX3 overexpressing cells. Overall, inhibition of DDX3 by RK 33 promotes tumor regression, thus providing a compelling argument to develop DDX3 inhibitors for lung cancer therapy. RK 33 radiosensitizes prostate cancer cells by blocking the RNA helicase